Forget Zepbound: Lilly's Next Stock Signal for Investors
Lilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
Explore ways to invest for quick returns to pay debt and improve your financial situation. Start making informed investment choices now!
21,539 articlesLilly’s Zepbound has shaken up the obesity-drug market, but the real upside could come from its next-generation candi...
In 2026, XMAG has surged while MAGS has slipped, underscoring a shift from mega-cap AI bets to broad-market exposure....
Two bold bets sit at the frontier of transport and connectivity: a space-based mobile network and a next-gen urban ai...
Palantir’s business is booming, yet its stock has struggled. This article breaks down why growth and stock moves aren...
Venture funding in the U.S. hit a record in the first half of 2026, led by AI mega-deals, while exits skew toward Spa...
Cardano ADA faces a tough patch near sub-$0.20 as bullish predictions mount, while Solana SOL hints at a rally. Here ...
Xenon stock sits at $42 as insiders trim significant positions ahead of a pivotal March Phase 3 readout. This guide b...
Bitcoin rose back toward the mid-60s, fueled by renewed risk appetite and easing inflation signals. This crypto price...
Hedge funds linked to Millennium Management are expanding IVV positions as markets wobble, intensifying chatter aroun...
Si-Bone stock soared almost 20% on Tuesday as investors reacted to strong quarterly results and optimistic guidance. ...
Healthcare often proves more resilient than broader markets. This guide highlights three durable healthcare ETFs and ...
Archer Aviation stock popped last month as investors weighed milestones in eVTOL development, defense partnerships, a...